Updated product metrics based on weekly prescription trends for key Aerie Pharmaceuticals products are herein. With the latest weekly Rxs, we estimate Aerie’s combined glaucoma franchise is annualizing at $81M in sales.RhopressaRhopressa is in its 32nd month of full-scale launch, and the latest wee

Equity Analysis /
United States of America